VP Venture Partners
VC Fund
Zürich, Switzerland
VP Venture Partners is a venture capital firm invests in healthcare companies.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 29%
Last updated:
For AI agents: llms.txt
Industries VP Venture Partners invests in
Stages VP Venture Partners invests in
Countries VP Venture Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $3M–$6.9M
- Series B
- $7.5M–$16M
Investment Focus
Industry
- Medical 3 (43%)
- Health Care 3 (43%)
- Biotechnology 3 (43%)
- Health Diagnostics 3 (43%)
- Medical Device 2 (29%)
Stage
- Seed 3 (43%)
- Pre-Seed 1 (14%)
- Series B 1 (14%)
- Convertible Note 1 (14%)
Country
- Austria 2 (29%)
- Germany 2 (29%)
- Switzerland 2 (29%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Valentin Piech
Founder
|
Founder | Total investments: 2 | Find email | |
Ruth Ketley
Senior Associate
|
Senior Associate | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| CollimateHealth is creating a clinically scalable microbeam radiation technology that will revolutionize the treatment of cancer. | $6.9M / Seed / Jun 12, 2026 | ||
| Moonlight AI empowers pathologists and hematologists to make therapeutic decisions backed by genomic insight. Moonlight AI was founded in 2022 and is headquartered in Jura, Switzerland. | $3.3M / Seed / May 06, 2026 | ||
| Diamens is a company focused on femtech that develops a non-invasive menstrual blood-based molecular diagnostic to detect women-specific diseases like endometriosis. | Pre-Seed / Mar 17, 2026 | ||
| aTension.life is a company focused on advancing the diagnosis and treatment of hypertension through precision medicine. It employs cutting-edge mass spectrometry technology to identify the underlying causes of uncontrolled hypertension using a single blood sample. aTension.life aims to provide personalized diagnostic solutions that enhance patientcare and support laboratories with accurate and reliable tools. The company's mission is to improve the quality of life for hypertensive patients by making advanced diagnostics widely accessible and enabling more effective, individualized therapies. | $3M / Seed / Apr 10, 2025 | ||
| Hemotune is a medical device company that develops a therapeutic blood purification platform for treatment of health ailments. | $15.6M / Series B / Mar 25, 2024 | ||
| Smart4Diagnostics is a manufacturer of a device for blood sample measurement. | $3.9M / Convertible Note / May 09, 2023 | ||
| Hemotune is a medical device company that develops a therapeutic blood purification platform for treatment of health ailments. | $7.5M / Series B / Apr 26, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does VP Venture Partners invest in?
VP Venture Partners invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed and Pre-Seed stage. Most of the 7 investments tracked by Shizune back companies in Austria. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is VP Venture Partners's check size?
VP Venture Partners typically joins rounds of $3M–$6.9M at Seed and $7.5M–$16M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds VP Venture Partners participates in.
How do I contact VP Venture Partners?
Public channels for VP Venture Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at VP Venture Partners?
The team at VP Venture Partners includes Valentin Piech (Founder) and Ruth Ketley (Senior Associate). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
